pharmaphorum4 年
Mission successful for Novartis after FDA approves ofatumumab in MS
Ofatumumab was first approved by the FDA as a cancer drug in chronic lymphocytic leukaemia (CLL), under the brand name Arzerra, in 2014 when it was owned by GlaxoSmithKline.